Unknown

Dataset Information

0

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer.

ABSTRACT: Lung cancer is the leading cause of cancer death worldwide and accounts for more than one-third of all newly diagnosed cancer cases in China. Therefore, it is of great clinical significance to explore new driver gene mutations in non-small-cell lung cancer (NSCLC). Using an initial bioinformatic analysis, we identified somatic gene mutations in 13 patients with NSCLC and confirmed these mutations by targeted sequencing in an extended validation group of 88 patients. Recurrent mutations were detected in UNC5D (7.9%), PREX1 (5.0%), HECW1 (4.0%), DACH1 (2.0%), and GPC5 (2.0%). A functional study was also performed in UNC5D mutants. Mutations in UNC5D promoted tumorigenesis by abolishing the tumor suppressor function of the encoded protein. Additionally, in ten patients with lung squamous cell carcinoma, we identified mutations in KEAP1/NFE2L2 that influenced the expression of target genes in vivo and in vitro. Overall, the results of our study expanded the known spectrum of driver mutations involved in the pathogenesis of NSCLC.

SUBMITTER: Zhang M 

PROVIDER: S-EPMC7377869 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer.

Zhang Manman M   Zhang Lele L   Li Yan Y   Sun Feng F   Fang Ya Y   Zhang Ruijia R   Wu Jin J   Zhou Guanbiao G   Song Huaidong H   Xue Liqiong L   Han Bing B   Zheng Cuixia C  

Aging 20200706 13

Lung cancer is the leading cause of cancer death worldwide and accounts for more than one-third of all newly diagnosed cancer cases in China. Therefore, it is of great clinical significance to explore new driver gene mutations in non-small-cell lung cancer (NSCLC). Using an initial bioinformatic analysis, we identified somatic gene mutations in 13 patients with NSCLC and confirmed these mutations by targeted sequencing in an extended validation group of 88 patients. Recurrent mutations were dete  ...[more]

Similar Datasets

Unknown Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.
| S-EPMC3499051 | biostudies-literature
Unknown Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
| S-EPMC3432702 | biostudies-literature
Unknown Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma.
| S-EPMC4621504 | biostudies-literature
Unknown Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
| S-EPMC4302757 | biostudies-literature
Unknown Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.
| S-EPMC4073211 | biostudies-literature
Unknown Whole-Exome Sequencing Identifies Novel Somatic Mutations in Chinese Breast Cancer Patients.
| S-EPMC4747093 | biostudies-literature
Unknown Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.
| S-EPMC3515204 | biostudies-literature
Unknown Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer.
| S-EPMC8169683 | biostudies-literature
Unknown Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.
| S-EPMC5335658 | biostudies-other
Unknown Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
| S-EPMC4915822 | biostudies-literature